AMLX Operating Expenses
Amylyx Pharmaceuticals Inc · Operating Expenses
AMLX Operating Expenses
Latest reported$142.14Mperiod ending
AMLX TTM Operating Expenses ($45.17M → $142.14M)
TTM operating expenses
High-resolution chart · PNG
AMLX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 142,141,000 | |
| 139,164,000 | |
| 111,069,000 | |
| 114,561,000 | |
| 173,657,000 | |
| 175,727,000 | |
| 254,410,000 | |
| 311,576,000 | |
| 315,063,000 | |
| 342,712,000 | |
| 316,543,000 | |
| 283,045,000 | |
| 259,144,000 | |
| 240,962,000 | |
| 199,114,000 | |
| 150,378,000 | |
| 118,442,000 | |
| 71,847,000 | |
| 51,501,000 | |
| 45,172,000 |